Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oklahoma Healthcare Wire.
Press releases published on April 30, 2025
Fifty 1 Labs, Inc. Accelerates Growth with New CEO, BioSentry Division Launch and Shareholder Dividend; Company Pursues Strategic Growth Through UAV Partnership and Targeted Acquisitions in Advanced Tech and Wellness
GlobeNewswire
·
April 30, 2025
MELBOURNE, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty 1 Labs, Inc. (OTC: FITY), a leader in innovative technology and wellness solutions, is thrilled to announce that Michael Lawson has assumed the roles of Chief Executive Officer and …
AAPA 2025 Salary Report: Rising Compensation Confirms PA Profession’s Vital Role in Healthcare System
GlobeNewswire
·
April 30, 2025
Alexandria, Va., April 30, 2025 (GLOBE NEWSWIRE) -- The American Academy of Physician Associates (AAPA) has released the findings of its 2025 AAPA Salary Report, shedding light on key trends shaping the physician associate/assistant (PA) profession. …
INVO Fertility Announces 2024 Financial Results with 116% Annual Revenue Growth and Further Improvements in Adjusted EBITDA
GlobeNewswire
·
April 30, 2025
SARASOTA, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition and …
Helius Medical Technologies Announces Reverse Stock Split
GlobeNewswire
·
April 30, 2025
NEWTOWN, Pa., April 30, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, announced …
InspireMD to Present at Upcoming Bank of America 2025 Healthcare Conference
GlobeNewswire
·
April 30, 2025
MIAMI, April 30, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced management will present at the Bank of …
PathAI to Present at Digestive Disease Week
GlobeNewswire
·
April 30, 2025
BOSTON, April 30, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in AI-powered pathology solutions, today announced it will present research from the outputs of IBD ExploreTM and AIM-HI UCTM at Digestive Disease Week (DDW) from May 3-6, 2025, in San …
Medicenna Presents Promising Preclinical Data from its First-in-Class Tumor Targeted and Conditionally Activated Anti-PD-1-IL-2 Bifunctional Superkine at the Annual 2025 AACR Meeting
GlobeNewswire
·
April 30, 2025
MDNA113 is a novel IL-13Rα2 tumor-targeted and “masked” anti-PD-1-IL-2 Superkine (anti-PD1-IL-2SK), engineered to precisely deliver clinically validated anti-PD1 and IL-2SK to the tumor microenvironment (TME) IL-13Rα2 is overexpressed by some of the most “ …
Elligint Health Partners with CareCo to Transform Care Coordination and Utilization Management with Advanced AI Workflow Tools and Integrated AI-Powered VoIP System
GlobeNewswire
·
April 30, 2025
KINGSTON, Pa., April 30, 2025 (GLOBE NEWSWIRE) -- Elligint Health, parent company of VirtualHealth, is excited to announce a strategic partnership with CareCo to deliver next-generation healthcare solutions. This groundbreaking collaboration will integrate …
Magnesium Breakthrough Under Review: Does BiOptimizers Magnesium Breakthrough Work? Best Magnesium Supplements!
GlobeNewswire
·
April 30, 2025
Albany, New York, April 30, 2025 (GLOBE NEWSWIRE) -- Stress is responsible for a lot of illnesses, and contrary to what people believe, it does not enter the body out of thin air. A person becomes stressed when there is a deficiency of Magnesium in the …
Bioma Probiotics Reviews: Best Probiotic For Gut Health & Weight Loss Ingredients & Side Effects
GlobeNewswire
·
April 30, 2025
Albany, New York, April 30, 2025 (GLOBE NEWSWIRE) -- In the present health-aware world, probiotics have become a pillar for the upkeep of gut health and general well-being. Among the numerous choices out there, Bioma Probiotic is notable for its …
Cell Counting Market to Hit US$16.14 Billion by 2029 with 7.7% CAGR | MarketsandMarkets™.
GlobeNewswire
·
April 30, 2025
Delray Beach, FL, April 30, 2025 (GLOBE NEWSWIRE) -- The global cell counting market, valued at US$10.82 billion in 2023, is forecasted to grow at a robust CAGR of 7.7%, reaching US$11.12 billion in 2024 and an impressive US$16.14 billion by 2029. …
Lantheus Announces Alzheimer’s Disease Radiodiagnostic MK-6240 Meets Co-Primary Endpoints in Two Pivotal Studies
GlobeNewswire
·
April 30, 2025
BEDFORD, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, …
Kiniksa Pharmaceuticals Announces GRAMMY® Award-Winning Country Star, Carly Pearce, Joins the Life DisRPted™ Campaign, Adding to Voices Advocating for Awareness of Recurrent Pericarditis
GlobeNewswire
·
April 30, 2025
– Pearce joins NHL Hall-of-Famer, Henrik Lundqvist, to educate patients and caregivers about the importance of accurate and early diagnosis of recurrent pericarditis, a chronic autoinflammatory disease of the heart that is often underdiagnosed or …
Better Choice Company Completes Name Change to SRx Health Solutions Inc. and Begins Trading Under the Ticker Symbol ‘SRXH’ Today, Wednesday, April 30, 2025
GlobeNewswire
·
April 30, 2025
TAMPA, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (NYSE American: SRXH) (“Better Choice” or the “Company”), a leading global health and wellness company, today announced completing its name change to SRx …
Oncocyte Provides Positive Update on Clinical Trial Progress
GlobeNewswire
·
April 30, 2025
Central Institutional Review Board approved, final preparatory steps underway at first transplant centers Three of the top 10 U.S. transplant centers expected to participate in trial Nearly 10% of annual U.S. transplant volume represented in trial site …
Cellectar Announces Plan to Explore Strategic Alternatives
GlobeNewswire
·
April 30, 2025
FLORHAM PARK, N.J., April 30, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today …
Catalyst Pharmaceuticals to Participate in the BofA Securities Health Care Conference 2025
GlobeNewswire
·
April 30, 2025
CORAL GABLES, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for …
Folia Health and Inspire are Partnering to Bring Personalized Home Health Observations to the Forefront of Patient Focused Drug Development Research
GlobeNewswire
·
April 30, 2025
BOSTON, April 30, 2025 (GLOBE NEWSWIRE) -- Folia Health, the pioneer of patient-driven Home Reported Outcomes (HRO), has partnered with Inspire, the world's leading online health community and real-world data platform, to uniquely empower patients and …
BioAtla to Participate in the Citizens Life Sciences Conference
GlobeNewswire
·
April 30, 2025
SAN DIEGO, April 30, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today …
Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2025 Financial Results on May 7
GlobeNewswire
·
April 30, 2025
DUBLIN, Ireland, April 30, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it will host a conference call and live webcast at 8:00 a. …